A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Clinical trial NCT01176240 · COMPLETED

Trial details

NCT number: NCT01176240
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Orthostatic Hypotension Parkinson's Disease

Start date: 2010-06-01
Primary completion: 2012-10-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.